Literature DB >> 33767265

Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates.

Wakako Mori1, Keisuke Yuzu1, Nadine Lobsiger1,2, Hideo Nishioka3, Hisako Sato1, Terumasa Nagase4, Keiichi Iwaya5, Mikael Lindgren6, Tamotsu Zako7.   

Abstract

Insulin balls, localized insulin amyloids formed at subcutaneous insulin-injection sites in patients with diabetes, cause poor glycemic control owing to impairments in insulin absorption. Our previous study has shown that some insulin balls are cytotoxic, but others are not, implying amyloid polymorphism. Interestingly, the patient with toxic insulin balls had been treated with antibiotic minocycline, suggesting a possible relationship between toxicity of insulin balls and minocycline. However, the direct effect of minocycline on the structure and cytotoxicity of the insulin amyloid is still unclear. Herein, we demonstrated that that minocycline at physiological concentrations induced degradation of insulin amyloids formed from human insulin and insulin drug preparations used for diabetes patients. Interestingly, the process involved the initial appearance of the toxic species, which subsequently changed into less-toxic species. It is also shown that the structure of the toxic species was similar to that of sonicated fragments of human insulin amyloids. Our study shed new light on the clarification of the revelation of insulin balls and the development of the insulin analogs for diabetes therapy.

Entities:  

Year:  2021        PMID: 33767265     DOI: 10.1038/s41598-021-86001-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

1.  The insulin ball.

Authors:  Terumasa Nagase; Yoshiya Katsura; Yoshiki Iwaki; Kenji Nemoto; Hidenori Sekine; Kazuhiro Miwa; Tsunao Oh-I; Keni Kou; Keiichi Iwaya; Masayuki Noritake; Takeshi Matsuoka
Journal:  Lancet       Date:  2009-01-10       Impact factor: 79.321

2.  Three-dimensional atomic structure of insulin and its relationship to activity.

Authors:  T L Blundell; J F Cutfield; S M Cutfield; E J Dodson; G G Dodson; D C Hodgkin; D A Mercola
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

3.  Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.

Authors:  Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-Ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark
Journal:  Amyloid       Date:  2016-11-24       Impact factor: 7.141

Review 4.  Amyloid oligomers: formation and toxicity of Abeta oligomers.

Authors:  Masafumi Sakono; Tamotsu Zako
Journal:  FEBS J       Date:  2010-02-09       Impact factor: 5.542

Review 5.  Insulin analogs: Glimpse on contemporary facts and future prospective.

Authors:  Arun K Sharma; Gaurav Taneja; Ashish Kumar; Megha Sahu; Gunjan Sharma; Asim Kumar; Satish Sardana; Aakash Deep
Journal:  Life Sci       Date:  2019-01-10       Impact factor: 5.037

Review 6.  Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.

Authors:  Amir Mehdi Ansari; Lais Osmani; Aerielle E Matsangos; Qing K Li
Journal:  Pathol Res Pract       Date:  2017-09-01       Impact factor: 3.250

7.  Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix.

Authors:  C Blake; L Serpell
Journal:  Structure       Date:  1996-08-15       Impact factor: 5.006

8.  Insulin-derived amyloidosis and poor glycemic control: a case series.

Authors:  Terumasa Nagase; Keiichi Iwaya; Yoshiki Iwaki; Fumio Kotake; Ryuji Uchida; Tsunao Oh-i; Hidenori Sekine; Kazuhiro Miwa; Satoshi Murakami; Tomotada Odaka; Masahiko Kure; Yoko Nemoto; Masayuki Noritake; Yoshiya Katsura
Journal:  Am J Med       Date:  2014-01-21       Impact factor: 4.965

9.  Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient.

Authors:  F E Dische; C Wernstedt; G T Westermark; P Westermark; M B Pepys; J A Rennie; S G Gilbey; P J Watkins
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

10.  Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases.

Authors:  Terumasa Nagase; Keiichi Iwaya; Koichiro Kogure; Tamotsu Zako; Yohei Misumi; Minoru Kikuchi; Koichi Matsumoto; Masayuki Noritake; Yasuhiro Kawachi; Masaki Kobayashi; Yukio Ando; Yoshiya Katsura
Journal:  J Diabetes Investig       Date:  2020-01-19       Impact factor: 4.232

View more
  4 in total

1.  Multistep growth of amyloid intermediates and its inhibition toward exploring therapeutic way: A case study using insulin B chain and fibrinogen.

Authors:  Naoki Yamamoto; Eri Chatani
Journal:  Biophys Physicobiol       Date:  2022-05-10

2.  Differences in interaction lead to the formation of different types of insulin amyloid.

Authors:  Wakako Mori; Ryosuke Kawakami; Yosuke Niko; Tomohiro Haruta; Takeshi Imamura; Kentaro Shiraki; Tamotsu Zako
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

3.  Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies.

Authors:  Mie Kristine Just; Hjalte Gram; Vasileios Theologidis; Poul Henning Jensen; K Peter R Nilsson; Mikael Lindgren; Karoline Knudsen; Per Borghammer; Nathalie Van Den Berge
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

4.  Insulin amyloid fibrils interact directly with the NLRP3, resulting in inflammasome activation and pyroptotic cell death.

Authors:  Wakako Mori; Naoe Kaneko; Ayaka Nakanishi; Tamotsu Zako; Junya Masumoto
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.